Davie
Davie
Davie, Florida, United States22 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-10-07 | NCT06653153 | |
| STOP AF First Post-Approval Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, paroxysmal atrial fibrillation | Active, not recruiting | Not stated | 2026-09-23 | NCT05227053 | |
| Product Surveillance Registry | Aneurysm, Arterial Occlusive Diseases, Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, arteriosclerosis disorder, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, intracranial arterial disease, kidney disorder, kidney failure, myocardial ischemia, nervous system disorder, otorhinolaryngologic disease, urinary system disorder, vascular disorder | Recruiting | Not stated | 2026-09-18 | NCT01524276 | |
| A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorder | Recruiting | Phase 3 | 2026-09-17 | NCT06671483 | |
| Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Not applicable | 2026-08-31 | NCT07108166 | |
| ASSESS ALL ALS Study | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not stated | 2026-08-24 | NCT06578195 | |
| Tongue-strengthening Exercises in People With ALS. | Deglutition Disorders, Digestive System Diseases, Dysarthria, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, articulation disorder, central nervous system disorder, communication disorder, digestive system disorder, esophageal disorder, language disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, otorhinolaryngologic disease, proteostasis deficiencies, speech disorder, spinal cord disorder | Recruiting | Not applicable | 2026-08-12 | NCT07295990 | |
| Study of COYA 302 for the Treatment of ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 / Phase 3 | 2026-08-06 | NCT07161999 | |
| Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease | Insulin Resistance, Nutritional and Metabolic Diseases, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-07-22 | NCT05266417 | |
| STOP Persistent AF PAS | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Active, not recruiting | Not stated | 2026-07-22 | NCT05005949 | |
| HEALEY ALS Platform Trial - Master Protocol | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-07-21 | NCT04297683 | |
| Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease. | Facial Pain, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not applicable | 2026-05-27 | NCT07187388 | |
| A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Active, not recruiting | Phase 3 | 2026-05-22 | NCT06812325 | |
| Rh-PDGF vs EMD for Treatment of Intra-bony Defects | Intrabony Periodontal Defect | Recruiting | Phase 1 / Phase 2 | 2026-04-16 | NCT05442034 | |
| Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not applicable | 2026-02-27 | NCT06581523 | |
| Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Enrolling by invitation | Not applicable | 2026-02-25 | NCT07298486 | |
| Mitigating Response to Stressors in Pregnant Women | Pregnancy | Recruiting | Not applicable | 2026-02-25 | NCT06718907 | |
| Assessing the Gut Microbiome and Its Association With Pediatric Stress and Cognition | Fractures, Stress, autism spectrum disorder, bone fracture, injury, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-02-25 | NCT06269614 | |
| Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2025-11-20 | NCT03970343 | |
| Left vs Left Randomized Clinical Trial | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2025-10-02 | NCT05650658 | |
| Study of Bacopa in Gulf War Illness Patients | Gulf War Illness | Recruiting | Phase 2 | 2025-07-04 | NCT04927338 | |
| Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY) | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Not yet recruiting | Phase 3 | 2025-05-22 | NCT06973629 |